Moreover, the proliferation marker Ki-67 was abundantly expressed by tumor-infiltrating CD8+ T cells expressing CD431B11, KLRG1, and NKG2A, whereas PDOX therapy only significantly increased KLRG1/Ki-67 double-positive cells (Figures 6C and S6E). This evidence concerns the gene KLRC1 and neoplasm.